行业概览 2024 年在大宗农产品原料价格下行的背景下，农林牧渔行业整体营收小幅下滑，但是原材料成本的下降利好养殖板块 的盈利回暖，在生猪养殖产能去化的驱动下，生猪养殖板块盈利实现明显好转，禽养殖板块实现稳健盈利，农业板块 整体盈利表现明显改善。2024 年农林牧渔板块实现营业收入为 1.24 万亿，同比-4.06%；实现归母净利润 479.85 亿 元，同比由亏转盈，养殖板块盈利出现明显改善。2024Q4 板块实现营业收入 3496.94 亿元，同比+0.98%，实现归母净 利润 162.09 亿元，同比+293.20%；2025Q1 板块实现营业收入 2907 亿元，同比+4.44%，实现归母净利润 133.35 亿元， 同比实现扭亏为盈，农林牧渔板块盈利实现好转。 生猪养殖 2024 年生猪养殖板块景气回升，2024 年实现收入 4832.76 亿元，同比-2.98%；实现归母净利润 331.42 亿元，同比扭 亏为盈，板块盈利明显改善。2025Q1 板块实现收入 1188.88 亿元，同比+17.32%；实现归母净利润 81.51 亿元，同比 扭亏为盈，在头部企业出栏量持续增加与养殖成本持续改善的背景 ...

Group 1: Swine Industry - The domestic supply and demand for pigs is expected to improve marginally by Q2 2025, with pig prices supported and entering a phase of gradual upward movement. External factors such as tariff-driven increases in feed raw material prices and higher costs for imported meat are also contributing positively to pig prices. The swine sector is highlighted as a defensive asset amid macroeconomic shocks, reinforcing investment logic. Recommended stocks include Wens Foodstuff Group, Muyuan Foods, and Juxing Agriculture [4][86]. - In 2024, China's pork production is projected to reach 56.75 million tons, accounting for 49% of global production, with consumption at 57.95 million tons, representing 50% of global consumption. This positions China as the world's largest pork producer and consumer [13][15]. - The average price of pork in 2024 is estimated at 16.8 yuan per kilogram, reflecting an increase of 11.8% year-on-year. The swine farming market size is expected to reach 1.5 trillion yuan, up 11.2% year-on-year [17][32]. Group 2: Poultry Industry - The demand for white chicken remains resilient despite uncertainties from U.S.-China tariff policies and avian influenza outbreaks. The consumption of white feather broilers is expected to improve marginally, with recommended stocks including San Nong Development and He Feng Co [5][94]. - In 2024, the total output of meat chickens in China is projected to reach 14.84 billion, with white feather broilers accounting for 60.85% of this figure. The output of white feather broilers is expected to increase by 2.2% year-on-year [99]. Group 3: Animal Health - The market for piglets and poultry chicks is stable, with a solid demand for poultry chicks supported by increasing poultry farming. The market for ruminant and pet vaccines is also expected to remain robust, with recommended stocks including Bio-Group, Kexin Biology, and Pulaike [6]. Group 4: Planting and Seeds - The focus on food security is emphasized, with companies involved in high-yield genetically modified soybeans likely to benefit from the ongoing U.S.-China trade tensions. The third batch of genetically modified corn varieties is expected to be approved for planting, which may increase the area under cultivation [7]. Group 5: Feed Industry - The recovery of the swine sector is expected to boost domestic demand for feed, while overseas markets present new growth opportunities. The demand for pig feed is anticipated to rebound as pig farming profitability improves and pig stocks gradually recover [8]. Group 6: Pet Industry - The upcoming shopping festivals are expected to drive demand for pet food, with domestic brands likely to gain market share due to increased tariffs on imported high-end products. Recommended stocks include Guibao Pet, Zhongchong Co, and Petty Co [6].

证券代码：000998 证券简称：隆平高科 公告编号：2025-26 袁隆平农业高科技股份有限公司 关于子公司为子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 截至本公告披露日，公司及控股子公司签署担保协议余额超过公司最近一期 经审计净资产 50%，敬请投资者注意相关风险。 一、担保情况概述 袁隆平农业高科技股份有限公司（以下简称"公司"）于 2024 年 4 月 25 日、 2024 年 5 月 20 日分别召开第九届董事会第十次会议、2023 年度股东大会审议通 过了《关于子公司向银行申请综合授信并提供担保的议案》，同意子公司为子公 司提供担保额度 500,000.00 万元人民币（或等值外币），担保方式为连带责任保 证担保或子公司资产抵押担保等，具体以签订的合同为准。本次担保额度有效期 为公司2023年度股东大会审议通过之日起至2024年度股东大会审议通过召开之 日止。具体内容详见公司于 2024 年 4 月 29 日刊登在巨潮资讯网（http://www.cn info.com.cn）上的《关于子公司向银行申请综合 ...

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Viewpoints - The corn seed market is experiencing a downturn, leading to short-term pressure on revenue and profits. In 2024, the company achieved operating revenue of 8.566 billion yuan, a decrease of 7.13% year-on-year, and a net profit attributable to the parent company of 114 million yuan, down 43.08% year-on-year. Excluding non-recurring gains and losses, the net profit was -289 million yuan, a significant decline of 159.31% year-on-year [1][8] - The hybrid rice seed business has seen growth in both volume and profit due to innovation and business synergy, with revenue reaching 2.008 billion yuan in 2024, an increase of 12.97% year-on-year [2] - The company is adjusting production and reducing seed inventory, resulting in improved inventory turnover efficiency. The inventory turnover days decreased by approximately 20 days year-on-year to 168.6 days in 2024 [3] Summary by Sections Revenue and Profit Performance - In 2024, the company reported total operating revenue of 85.66 billion yuan, down 7.13% year-on-year, primarily due to the global grain price decline affecting corn seed sales [1][8] - The net profit attributable to the parent company for 2024 was 1.14 billion yuan, a decrease of 43.08% year-on-year, with significant losses attributed to reduced main business income and increased financial expenses due to exchange rate fluctuations [1][8] Segment Performance - The corn seed segment generated revenue of 50.21 billion yuan in 2024, a decline of 16.74% year-on-year, with a gross margin of 34.63%, down 5.38 percentage points [2] - The hybrid rice seed segment achieved revenue of 20.08 billion yuan in 2024, an increase of 12.97% year-on-year, with a gross margin of 37.60%, up 1.23 percentage points [2] Financial Forecasts - The company has revised its net profit forecasts for 2025 and 2026 to 200 million yuan and 470 million yuan, respectively, down from previous estimates of 370 million yuan and 620 million yuan [19] - The projected earnings per share for 2025, 2026, and 2027 are 0.2 yuan, 0.4 yuan, and 0.5 yuan, respectively [19] Market Position and Future Outlook - As a leading player in the domestic corn seed market, the company is expected to benefit from the increasing penetration of genetically modified corn, which may lead to a rebound in both volume and profit in the future [19]

Investment Rating - Industry rating: Outperform the market (maintained rating) [15] Core Views - The pig farming sector shows significant profitability but with large disparities due to cost differences, leading to a "stronger becoming stronger" scenario [19][21] - The poultry sector is experiencing a structural decline in production capacity, with a focus on the white chicken segment as it approaches its lowest point [22][24] - The seed industry faces inventory pressure, but the biological breeding sector is expected to accelerate due to supportive policies [29][30] - The pet industry is witnessing rapid growth of domestic brands, with a focus on high-income growth companies [32][33] - The feed sector is recommended for investment due to improving market demand and cost control capabilities [34] Summary by Sections Pig Farming Sector - Q1 sales prices for pigs were low, averaging 14.5-15.5 CNY/kg, down from 16-17 CNY/kg in Q4 2024 [19] - Companies like Shennong and Juxing saw over 60% year-on-year growth in output [19] - Average profit per pig improved significantly, with leading companies achieving profits of 300-350 CNY per head [19][21] - Some companies are returning cash to shareholders with high dividend payout ratios [19] Poultry Sector - The white chicken segment is under pressure, with significant price declines and narrowing profits [22] - The egg-laying chicken sector is benefiting from rising chick prices and sales, with companies like Xiaoming showing substantial profit growth [28] - The yellow chicken segment is experiencing a supply contraction, with demand expected to improve gradually [26][27] Seed Industry - The seed sector is under pressure with a net profit decline of 37.6% in Q1, primarily due to excess supply [29] - High R&D investment is noted, with leading companies like Longping High-Tech maintaining a strong position [29][30] - New regulations are expected to bolster the biological breeding sector, enhancing competitiveness [30][31] Pet Industry - Major pet food companies reported strong revenue growth, with brands like Maifudi leading the market [32] - The demand for elderly pet care products is increasing significantly, indicating a shift in consumer preferences [32] - The pet economy is thriving, with a focus on high-growth domestic brands [33] Feed Sector - The feed sector is recommended for investment, with companies like Haida Group showing improved revenue and profit [34] - The market for aquaculture feed is expected to recover, driven by rising fish prices and supportive consumption policies [34] Animal Health Sector - The animal health sector is experiencing revenue and profit differentiation, with some companies benefiting from price increases in raw materials [35] - New product opportunities in the pet health segment are emerging, providing potential growth avenues [35][36]

证券研究报告|公司点评报告 [Table_Date] 2025 年 04 月 30 日 [Table_Title] 玉米业务短期承压，水稻业务韧性凸显 [Table_Title2] 隆平高科(000998) | [Table_DataInfo] 评级： | 买入 | 股票代码： | 000998 | | --- | --- | --- | --- | | 上次评级： | | 52 周最高价/最低价： | 12.99/8.96 | | 目标价格： | | 总市值(亿) | 133.28 | | 最新收盘价： | 10.12 | 自由流通市值(亿) | 133.08 | | | | 自由流通股数(百万) | 1,315.05 | [Table_Summary] 事件概述 公司发布 2025 年第一季度报告，报告期内，公司实现营业收入 14.09 亿元，同比下降 32.03%；实现归母净利 润-209 万元，同比下降 102.72%，由盈转亏；实现扣非归母净利润 1074 万元，同比下降 85.19%。 分析判断: ► 玉米业务拖累整体业绩，水稻业务展现韧性 2025 年一季度公司营收及利润出现下滑，主要原因系报告 ...

证券研究报告|公司点评报告 [Table_Date] 2025 年 04 月 30 日 [Table_Title] 玉米业务短期承压，水稻业务韧性凸显 [Table_Title2] 隆平高科(000998) | [Table_DataInfo] 评级： | 买入 | 股票代码： | 000998 | | --- | --- | --- | --- | | 上次评级： | | 52 周最高价/最低价： | 12.99/8.96 | | 目标价格： | | 总市值(亿) | 133.28 | | 最新收盘价： | 10.12 | 自由流通市值(亿) | 133.08 | | | | 自由流通股数(百万) | 1,315.05 | [Table_Summary] 事件概述 公司发布 2025 年第一季度报告，报告期内，公司实现营业收入 14.09 亿元，同比下降 32.03%；实现归母净利 润-209 万元，同比下降 102.72%，由盈转亏；实现扣非归母净利润 1074 万元，同比下降 85.19%。 分析判断: ► 玉米业务拖累整体业绩，水稻业务展现韧性 2025 年一季度公司营收及利润出现下滑，主要原因系报告 ...

Core Insights - The Chinese biotechnology industry, focusing on biopharmaceuticals, biomanufacturing, and bioagriculture, is experiencing high-quality development supported by national policies, with a projected industry scale of 21.4 trillion yuan in 2024, representing a year-on-year growth of 3.88% [1][8] - Technological innovation is identified as the core engine for industry advancement, with significant breakthroughs in gene editing, synthetic biology, and cell therapy, enhancing China's competitive position in the global biotechnology landscape [1][8] Industry Overview - The biotechnology sector encompasses living organisms and is classified based on similarities in morphology and physiology, aiding in understanding evolutionary relationships [2] - The industry has evolved through five stages, from initial laboratory research in the 1980s to a focus on commercialization and internationalization in recent years [3][4][5] Market Scale - The biopharmaceutical sector is projected to face pricing pressures, with the PPI index for biopharmaceutical manufacturing at 95.7, down 4.3% year-on-year as of March 2025, yet the demand for biopharmaceuticals is expected to grow due to aging populations and increased health awareness [10] - The biomass power generation capacity in China is expected to reach 45.99 million kilowatts by 2024, with a year-on-year growth of 4.19%, indicating a significant role in the low-carbon energy transition [12] Key Enterprises - Major players in the biopharmaceutical sector include Huazhong Biotech, which has a comprehensive blood product portfolio and a significant vaccine production platform, and Longping High-Tech, known for its hybrid rice innovations and international breeding initiatives [18][20] - The biomanufacturing and bioenergy sectors are led by companies like Guoneng Bio and Malu Bio, focusing on biomass power generation and organic waste treatment, respectively [15][16] Industry Development Trends - Technological innovation is driving breakthroughs across multiple fields, including personalized medicine in biopharmaceuticals and enhanced efficiency in bioenergy production [22][23] - The integration of biomanufacturing and bioagriculture is expected to yield innovative solutions, improving resource utilization and creating a circular economy [25]

内容概况：农产品加工业是农业产业提质增效的最大空间，是统筹脱贫攻坚和乡村振兴的重要抓手，是 农业产业效益提升的重要途径。近年来，随着脱贫攻坚战取得全面胜利，贫困地区的交通条件、招商引 资、产业建设、民生保障等都发生了巨大变化。目前我国已经进入全面推进乡村振兴阶段，产业振兴是 乡村振兴的重要一环，乡村产业中农产品加工业是体量最大、产业关联度最高的产业。数据显示，2024 年全国规模以上农产品加工企业营业收入超18万亿元。农产品加工业的蓬勃发展，将成为推动乡村产业 振兴、促进农民增收致富的重要引擎，为乡村振兴战略的深入实施注入持久动力。 相关上市企业：苏垦农发（601952）、星光农机（603789）、敦煌种业（600354）、隆平高科 （000998）、梅安森（300275）、芭田股份（002170）、新洋丰（000902）、新希望（000876）、登海 种业（002041）、牧原股份（002714）等。 相关企业：浙江天顺控股集团有限公司、运鸿集团股份有限公司等。 关键词：乡村振兴战略、返乡入乡、国家农村产业融合发展示范园批准创建数量、国家现代农业产业 园、国家级农业产业强镇批准创建数量、规模以上农产品加工业 ...

Group 1: Company Performance Overview - The company achieved an annual revenue of 85.66 billion CNY, with a net profit attributable to shareholders of 5.4 billion CNY, driven by a robust domestic business that generated 54 billion CNY in revenue [3][4] - Domestic rice revenue grew by 13% on top of a 36% increase in 2023, surpassing 20 billion CNY, while corn revenue exceeded 21 billion CNY despite international market challenges [3][4] - The company maintained a stable market share of approximately 20% in Brazil, with sales remaining flat year-on-year despite adverse conditions [3][4] Group 2: Strategic Focus and Initiatives - The company is focusing on a "2+2" crop strategy, prioritizing corn and sorghum while also expanding into soybeans and rice [5][6] - Aiming to enhance profitability, the company plans to leverage its operational management capabilities in Brazil to meet high customer service and product quality demands [5][6] - The company is optimizing its research and product strategies to develop globally competitive products while reducing costs and improving efficiency [5][6] Group 3: Market Trends and Future Outlook - The Brazilian corn market is expected to see significant changes due to the government's new biofuel policy, which will increase ethanol production and subsequently corn demand [7][8] - The company anticipates a slight increase in corn prices by the end of the year, with a clear and sustainable growth trend in the industry [7][8] - The company is positioned to capitalize on market opportunities by deepening its core crop strategy of "corn + sorghum" to enhance market share and profitability [7][8] Group 4: Financial Management and Cost Control - The company has implemented financial strategies to manage high interest rates in Brazil, securing loans at a significantly lower rate of 2.9% compared to local rates exceeding 16% [9][10] - Management expenses have decreased by 22.9 million CNY year-on-year, reflecting the company's commitment to cost control and efficiency [9][10] - The company is adopting hedging tools to mitigate exchange rate risks associated with cross-border loans, ensuring stability in profit margins [9][10] Group 5: Research and Development Focus - The company is prioritizing the development of drought-resistant and high-yield corn varieties, with a focus on enhancing traits such as resistance to pests and diseases [16] - The integration of gene editing technology is expected to significantly shorten breeding cycles from 7-8 years to 5-6 years, facilitating the introduction of competitive varieties [16] - The company plans to expand its market presence in northern regions by launching early-maturing corn varieties and optimizing product structures [14][15]